about
Vasoactive drugs for acute strokeMonoaminergic agonists for acute traumatic brain injuryWhat is the role of brain mechanisms underlying arousal in recovery of motor function after structural brain injuries?Motor priming in neurorehabilitation.Long-term motor improvement after stroke is enhanced by short-term treatment with the alpha-2 antagonist, atipamezole.The DARS (Dopamine Augmented Rehabilitation in Stroke) trial: protocol for a randomised controlled trial of Co-careldopa treatment in addition to routine NHS occupational and physical therapy after stroke.The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisalEvidence for fibroblast growth factor-2 as a mediator of amphetamine-enhanced motor improvement following stroke.Pharmacologic approaches to cerebral aging and neuroplasticity: insights from the stroke model.Escitalopram and enhancement of cognitive recovery following stroke.Genetics as a molecular window into recovery, its treatment, and stress responses after strokeMotor recovery and axonal plasticity with short-term amphetamine after strokeA pragmatic strategy for the review of clinical evidence.Strategies to improve recovery in acute ischemic stroke patients: Iberoamerican Stroke Group Consensus.Recent advances in the treatment of post-stroke aphasia.Effects of monoaminergic drugs on training-induced motor cortex plasticity in older adults.Comparing Cerebralcare Granule and aspirin for neurological dysfunction in acute stroke in real-life practice.The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery
P2860
Q24236792-434B4A5F-67B1-44D7-B829-E06E9C255EC5Q24244201-02A18D7B-93A8-41AA-8C40-B12C9D337ABDQ27014122-26E0CDAA-1949-482B-B7FF-7CAD7430A7AEQ27314487-1D22F630-001F-4395-A0EF-C62007CC8614Q33998923-385B646B-63EF-411D-8B86-DB95CE9D02A3Q34067590-E3ABE99E-53DA-416F-9C8F-B5FE9C449AD4Q34207775-EBD9B48A-53A7-4C4C-B3DA-6B89212FE791Q35258422-B9B0A00F-76B8-4EA4-A59E-19A732333EECQ36755173-53DBD35E-D0DF-4C40-9461-9D269A5A8F82Q37032754-807ADFD5-A463-4D7A-B68A-C37FB0C07FDCQ37088174-4C3B4EBA-101D-4592-8655-1D7CA0D80A8FQ37249687-95D60000-A07B-4590-940F-F76EF0AEFBFBQ38073833-FCD8B1E2-5F17-4416-9B99-461B6BFF3125Q38117170-F91D6327-3C35-4BDB-AF01-A279D62F794DQ41907120-2D9CC49E-8D15-409A-9094-ED428A82A8AEQ45061758-C51EA9CF-7142-43D5-99A6-C00C0462A5BDQ50546619-F9BC3D0F-6E7F-4640-B8D4-E4D18EBC094FQ57176938-F236038A-0FAB-46ED-AA55-3AD66C34C34B
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Amphetamines for improving recovery after stroke
@ast
Amphetamines for improving recovery after stroke
@en
Amphetamines for improving recovery after stroke
@en-gb
Amphetamines for improving recovery after stroke
@nl
type
label
Amphetamines for improving recovery after stroke
@ast
Amphetamines for improving recovery after stroke
@en
Amphetamines for improving recovery after stroke
@en-gb
Amphetamines for improving recovery after stroke
@nl
prefLabel
Amphetamines for improving recovery after stroke
@ast
Amphetamines for improving recovery after stroke
@en
Amphetamines for improving recovery after stroke
@en-gb
Amphetamines for improving recovery after stroke
@nl
P2093
P2860
P1476
Amphetamines for improving recovery after stroke
@en
P2093
Hans-Göran Hårdemark
Louise Martinsson
Staffan Eksborg
P2860
P356
10.1002/14651858.CD002090.PUB2
P577
2007-01-24T00:00:00Z